Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7244558
Production of novel Newcastle disease virus strains from cDNAs and improved live attenuate
granted patentUS 7227011
Nucleic acid vaccines for prevention of flavivirus infection
granted patentUS 7226602
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted patentUS 7223585
Viral purification methods
granted patentUS 7223844
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus select
granted patentUS 7223787
Prenylation inhibitors reduce host cell permissiveness to viral replication
granted patentUS 7223388
Modified reoviral therapy
granted patentUS 7220419
Self-assembling recombinant papillomavirus capsid proteins
granted patentUS 7220852
Coronavirus isolated from humans
granted patentUS 7217812
Extraneous DNA sequence that facilitates hantavirus gene expression
granted patentUS 7217418
Multivalent dengue virus vaccine
granted patentUS 7214524
Marek's disease virus vaccine
granted patentUS 7211255
Contraceptives based on SP22 and SP22 antibodies
granted patentUS 7208313
Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector
granted patentUS 7208161
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
granted patentUS 7201911
Cloned genomes of infectious hepatitis C viruses and uses thereof
granted patentUS 7201907
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
granted patentUS 7198783
Sensitization of neoplastic cells to radiation therapy with reovirus
granted patentUS 7192593
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection an
granted patentUS 7189513
Human papilloma virus immunoreactive peptides
granted patentUS 7186542
Method of extracting virus from cell culture
granted patentUS 7183095
Cell culture system for synthesis of infectious hepatitis C virus
granted patentUS 7183268
2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents
granted patentUS 7163678
Reovirus for the treatment of ral-mediated cellular proliferative disorders
granted